Ireland
--:--IST
Recruiting Not applicable

Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery

NCT05361837 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2022-05-10
Last updated
2026-06-30

Condition(s) studied

Analgesia

Investigational drug(s) / intervention(s)

Single level serratus anterior plane blockSingle level serratus anterior plane block with dexmedetomidineBilevel serratus anterior plane blockBilevel serratus anterior plane block with dexmedetomidine

Single level serratus anterior plane block: Serratus anterior plane block with local anesthetics at the third rib

Single level serratus anterior plane block with dexmedetomidine: Serratus anterior plane block with local anesthetics and dexmedetomidine at the third rib

Bilevel serratus anterior plane block: Serratus anterior plane block with local anesthetics at the third and fifth rib

Bilevel serratus anterior plane block with dexmedetomidine: Serratus anterior plane block with local anesthetics and dexmedetomidine at the third and fifth rib

Study summary

This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * patients scheduled for modified radical mastectomy, * Age 18-65 years, * ASA I-II Exclusion Criteria: * patient refusal, * coagulation defects, * abnormal kidney or liver functions, * local infection at site of injection.

Primary outcome measure(s)

  • First time to receive analgesia — First 24 hours postoperatively
    first time to receive morphine analgesia in hours
  • Total analgesic requisite — First 24 hours postoperatively
    total amount of morphine consumption in the first 24 hours postoperatively in mg

Trial sites (1)

FacilityCityRegionStatus
Walaa Y Elsabeeny Cairo Cairo Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05361837 on ClinicalTrials.gov ↗ ← All trials in Egypt